U.S. Department of Health and Human Services — National Institutes of Health

PHOSPHORYLATION

Discover > PHOSPHORYLATION

3DPX-015298

Rsk2 C-terminal Kinase Domain with inhibitor...
bejan3D

KINASE, INHIBITOR, reversible, thiol, PHOSPHORYLATION, migration, TRANSFERASE-TRANSFERASE INHIBITOR complex

3DPX-015297

Rsk2 C-terminal Kinase Domain, (E)-tert-...
bejan3D

KINASE, reversible inhibitor, PHOSPHORYLATION, TRANSFERASE-TRANSFERASE INHIBITOR complex

3DPX-015017

Structure of PLK1 in complex with BI2536
Christopher Hastings

Structure of PLK1, selectivity residues, KINASE, polo-like kinase, structure based drug design, ATP-binding, Nucleotide-binding, NUCLEUS, PHOSPHORYLATION, SERINE/THREONINE-PROTEIN KINASE

3DPX-014203

Crystal structure of serum and...
anajafov

AGC PROTEIN KINASE, Apoptosis, ATP-binding, endoplasmic reticulum, Nucleotide-binding, NUCLEUS, PHOSPHORYLATION, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, KINASE

3DPX-013006

Full-length human CaMKII
caklemens

KINASE, PROTEIN KINASE, PHOSPHORYLATION, Calcium/calmodulin, cytosolic, TRANSFERASE-TRANSFERASE INHIBITOR complex

3DPX-012725

Crystal structure of S6K1 kinase domain in...
jubilantsundar

SERINE/THREONINE PROTEIN KINASE DOMAIN, TRANSFERASE, PHOSPHORYLATION, ATP-binding, zinc-binding, TRANSFERASE-TRANSFERASE INHIBITOR complex

3DPX-012536

Apo structure of the catalytic subunit of...
dwyert2

Protein kinase fold, phosphoryl transferase, KINASE, regulatory subunit of PKA, PKI, PHOSPHORYLATION, TRANSFERASE

3DPX-012347

MDM2 BOUND TO THE TRANSACTIVATION DOMAIN OF...
shanelacanin

ANTI-ONCOGENE, DNA-binding, TRANSCRIPTION REGULATION, NUCLEAR PROTEIN, COMPLEX (ONCOGENE PROTEIN-PEPTIDE), PHOSPHORYLATION, activator, COMPLEX (ONCOGENE PROTEIN-PEPTIDE) complex